Key result
PDE4D SNP56 TT genotype is linked to ~29% higher ischemic stroke risk vs AA.
Why the study?
Previous studies on the association between PDE4D gene variants and ischemic stroke showed conflicting results due to small sample sizes and study heterogeneity.
Are PDE4D gene variants associated with an increased risk of ischemic stroke?
Meta-Analysis (n=27,067)
Are PDE4D gene variants associated with an increased risk of ischemic stroke?
Odds Ratio: 1.29 (95% CI 1.03–1.61)
p-value: p=0.022
This meta-analysis confirms a significant association between specific PDE4D gene variants and the risk of ischemic stroke, with potential ethnic-specific effects.
PDE4D variants were associated with ischemic stroke risk in homogeneous subgroups; leaves open ethnic-specific effects for prospective validation.
BACKGROUND: An Icelandic study showed a significant positive association between phosphodiesterase 4D (PDE4D) gene variants and stroke. However, subsequent studies reported conflicting results, possibly due to small sample sizes and the heterogeneity of the studies. METHOD: We performed a meta-analysis on 6 SNPs of the PDE4D gene to investigate the association between this gene and ischemic stroke by integrating the results of previous studies, comprising 11,834 cases and 15,233 controls. A pooled genotypic odds ratio (OR) for each SNP was determined under 3 genetic models (i.e. dominant, recessive, and codominant) using both fixed- and random-effects models with consideration for heterogeneity and publication bias across studies. RESULTS: Among the SNPs included in this study, SNP56 (rs702553) showed the most significant association with ischemic stroke in a meta-analysis comprised of 7 homogenous studies. The overall OR of the TT genotype compared to the AA genotype was 1.29 (95% CI 1.03-1.61; p = 0.022). For SNP83 (rs966221), a protective effect of the ancestral allele T was observed only in Asian populations (ORTT 0.79, 95% CI 0.69-0.90; p = 0.0005). This meta-analysis revealed a significant association of PDE4D gene variants with the risk of ischemic stroke, and further investigations are warranted to evaluate possible ethnic-specific effects.
No takes yet. Share an insight, caveat, or question.
Yoon et al. (2011) conducted a meta-analysis in Ischemic stroke (n=27,067). PDE4D gene variants (SNP56 rs702553 TT genotype) vs. AA genotype was evaluated on Ischemic stroke (OR 1.29, 95% CI 1.03-1.61, p=0.022). The PDE4D gene variant SNP56 (rs702553) TT genotype was significantly associated with an increased risk of ischemic stroke compared to the AA genotype (OR 1.29; 95% CI 1.03-1.61; p=0.022).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: